May 2025 - Cancer Currents Blog
-
FDA Approval Likely to Change Initial Treatment for Some People with Advanced Colorectal CancerFDA has approved the combination of the immunotherapy drugs ipilimumab (Yervoy) and nivolumab (Opdivo) for the initial treatment of people with advanced colorectal cancer whose tumors are classified as MSI-H or dMMR.